References
- Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159–66.
- Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010;70:313–33.
- Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005;56:451–4.
- Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008;14: 159–65.
- Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13:1–11.
- Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, Cheasty T, et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008;62:1241–4.
- Shitrit P, Reisfeld S, Paitan Y, Gottesman BS, Katzir M, Paul M, et al. Extended-spectrum beta-lactamase- producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors. J Hosp Infect 2013; 85:230–2.
- Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae – a case-control study in a low prevalence country. PLoS One 2013;8:e69581.
- Tangden T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010;54:3564–8.
- Potz NA, Hope R, Warner M, Johnson AP, Livermore DM; London & South East ESBL Project Group. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006;58:320–6.
- Wickramasinghe NH, Xu L, Eustace A, Shabir S, Saluja T, Hawkey PM. High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. J Antimicrob Chemother 2012;67:1108–13.
- Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008;62: 256–78.
- Andrews JM. BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother 2007;60: 20–41.
- Andrews JM. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009;64: 454–89.
- Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013;34:361–9.
- Mandal J, Acharya NS, Buddhapriya D, Parija SC. Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res 2012;136:842–9.
- Data Management and Analysis Group (DMAG) - Mayor of London Office. ONS Ethnic Group Population Estimates; Mid-2006.
- Mathur R, Grundy E, Smeeth L. Availability and use of UK based ethnicity data for health research. National Centre for Research Methods Working Paper; 01/2013.
- Association of Public Health Observatories. Ethnicity and Health; 2005. Available from: http://www.apho.org.uk/resource/item.aspx?RID = 39368 (accessed 25/04/2015).
- Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, vanStaa T, Grundy E, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health 2014;36:684–692.